missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cytiva HiTrap™ MabSelect™ SuRe™ LX Columns
Shop All Cytiva Products
Click to view available options
Quantity:
10/Pk.
5/Pk.
Volume (Metric) Bed:
1 mL
5 mL
Unit Size:
Pack of 10
Pack of 5
Description
- Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH
- High dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used
- Generic elution profile for different monoclonal antibodies enables platform approach to purification
- High-flow agarose matrix allows the processing of large feed volumes
- Reduces the risk of product contamination and carryover
- Improves performance and reduces overall costs

Specifications
Specifications
Product Type | Antibody Purification Column |
Stationary Phase | MabSelect SuRe LX |
Flow Rate | 4 mL/min. (Max) |
Ligand | Protein A |
Particle Size | 85 ÎĽm |
Purification Target | Human IgG |
Volume (Metric) Bed | 1 mL |
For Use With (Application) | Purification of Human IgG |
Sample Volume | 1 to 30 mg/Column |
Quantity | 5/Pk. |
Safety and Handling

Product Identifier
- HiTrap MabSelect SuRe LX
- Warning
- Flammable liquid Category 3
- H226-Flammable liquid and vapour.
- P241-Use explosion-proof electrical/ventilating/lighting/ equipment.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contains : ethanol
- UNKNOWN ACUTE-16.5 per cent of the mixture consists of component(s) of unknown acute toxicity.
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Cytiva HiTrap™ MabSelect™ SuRe™ LX Columns >
Spot an opportunity for improvement?Share a Content Correction